METHOD FOR PRIMARY SCLEROGENIC PREVENTIVE HEMOSTASIS AT ESOPHAGUS AND STOMACH VARICOSE VEINS BLEEDING HEIGHT Russian patent published in 2017 - IPC A61B17/94 A61M5/00 A61K31/74 A61K33/40 A61P7/04 

FIELD: medicine.

SUBSTANCE: method comprises intravasal administration of Aethoxysklerol microfoam to the esophageal vein lumen. Microfoam is prepared by 3% Aethoxysklerol mixing with air at a ratio of 1:6 or 1% Aethoxysklerol mixing with air at a ratio of 2:6. The resulting 7-8 ml of Aethoxysklerol microfoam is introduced into the esophageal or stomach bleeding vein lumen via an injector 1.5 cm proximal to the bleeding source. If necessary, injections are repeated in other veins, further 2 ml of 1% hydrogen peroxide solution is administered paravasally submucosally at the cardia level from each side of the vein. Hemostasis is monitored after 8-12 hours, if necessary, the procedure is repeated after 6 days, 1, 3, 6 months.

EFFECT: method allows to effectively stop bleeding from varicose veins with simultaneous sclerotherapy, providing prevention of bleeding, is easy to use and safe.

6 dwg, 1 ex